Halozyme (NASDAQ:HALO) Soars to Six Year High Level after Pfizer (NYSE:PFE) Pact – HALO, BAX, VPHM, LLY

Halozyme Therapeutics, Inc’s (NASDAQ:HALO) stock hiked to record high level in 6 years after , the drug-delivery systems maker reported a collaboration with Pfizer Inc (NYSE:PFE), the world’s biggest drug manufacturer, to make around 6 inject able medicines.

Shares of the San Diego-based Halozyme moved up 27% to settle at $7.01 in New York and marked the record high single-day boost since December 2006.

The company reported in a statement on Friday that the pact comprises an $8 million payment to Halozyme.

Halozyme Therapeutics reported in a statement that the deal comprises a license to develop 2 specific treatments and the right for Pfizer to decide around 4 other targets.

Shifting reader’s focus to broader market, let us consider market performance of other stocks that significantly affect same sector. Baxter International Inc. (NYSE:BAX) fell -0.81% to settle at $67.25, Viropharma Inc (NASDAQ:VPHM) moved down -1.82% to end at $22.75 while Eli Lilly & Co. (NYSE:LLY) jumped +0.61% to finish at $49.55 on Friday.

Halozyme Therapeutics, Inc. (NASDAQ:HALO) last session’s volume of 9.02 million shares was surprisingly higher than its average volume of 642,773 shares. The stock after opening at $6.36 hit high price of $7.19 and then closed at $7.01 by scoring +26.99%.

The liquidity measure in recent quarter results of the company was recorded 5.02 as current ratio. The Company had total cash of $87.61 million at hand and a book value per share as $0.46 in the most recent quarter.

The stock’s price volatility was 6.37% for a week and 5.55% for a month as well as price volatility’s Average True Range for 14 days was 0.39 and its beta remained at 1.51.

HALO generated revenue of $22.94 million in the previous twelve months and earned -$67.56 million. The Company showed a negative -294.48% in the net profit margin as well as in its operating margin which remained at -294.85%. Company’s annual sales growth for the past five years was 124.57%.

DO NOT TRADE ANY STOCK WITHOUT LEVEL 2 STOCK QUOTES! QuoteDaddy.com delivers it's user with the most in-depth Level 2 Quotation System available on the Planet! NO Downloads, NO Widgets, NO Plugins required! Stay on TOP of your trades with QuoteDaddy.com! CLICK HERE TO START YOUR FREE 30-DAY TRIAL

This entry was posted in Healthcare, Latest Headlines and tagged , , , , , , , , , , , . Bookmark the permalink.